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Abstract
MHCII molecules are heterodimeric cell surface proteins composed of an a and b chain. These molecules are almost
exclusively expressed on thymic epithelium and antigen presenting cells (APCs) and play a central role in the development
and function of CD4 T cells. Various MHC-II knockout mice have been generated including MHC-IIAa-/- (I-Aa-/-), MHC-IIAb-/- (I-
b-/-) and the double knockout (I-Aaxb-/-). Here we report a very striking observation, namely that alphaviruses including the
avirulent strain of Semliki Forest virus (aSFV), which causes asymptomatic infection in wild-type C57BL6/J (B6) mice, causes a
very acute and lethal infection in I-Aa-/-, but not in I-b-/- or I-Aaxb-/-, mice. This susceptibility to aSFV is associated with high
virus titres in muscle, spleen, liver, and brain compared to B6 mice. In addition, I-Aa-/- mice show intact IFN-I responses in
terms of IFN-I serum levels and IFN-I receptor expression and function. Radiation bone marrow chimeras of B6 mice
reconstituted with I-Aa-/- bone marrow expressed B6 phenotype, whereas radiation chimeras of I-Aa-/- mice reconstituted
with B6 bone marrow expressed the phenotype of high viral susceptibility. Virus replication experiments both in vivo and in
vitro showed enhanced virus growth in tissues and cell cultures derived form I-Aa-/- compared to B6 mice. This enhanced
virus replication is evident for other alpha-, flavi- and poxviruses and may be of great benefit to producers of viral vaccines.
In conclusion, I-Aa-/- mice exhibit a striking susceptibility to virus infections independent of their defective MHC-II
expression. Detailed genetic analysis will be carried out to characterise the underlining genetic defects responsible for the
observed phenomenon.
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Introduction
The interplay between the innate and the adaptive arms of the
immune system is essential for the establishment of protective
immunity against harmful microbial infections. This protective
immunity involves differential recognition of infectious non-self
antigens. CD4+T cells, part of the adaptive immune response, play
a major role in orchestrating both humoral and cell-mediated
immunity. Importantly, helper and regulatory functions of CD4+
T cells involve antigen recognition through their TCRs, which
recognize processed peptide antigens presented by antigen
presenting cells (APCs) in the context of major histocompatibility
complex class II (MHC-II) molecules. Therefore, MHC-II
molecules play a central role in the development and function of
the immune system. Expression of MHC-II genes is tightly
regulated and mostly restricted to thymic epithelium [1,2] and
APCs [3,4]. MHC-II molecules are heterodimeric proteins and
there are two isotypic forms (I-A and I-E) expressed in mice. Each
isotypic form is composed of an a and b chain (Aa:Ab and Ea:Eb,
respectively). Thus, any strategy to generate MHC-II-deficient
(MHC-II-/-) mice requires the elimination of both I-A and I-E
expression. It is fortunate that H-2b mice (such as C57BL6/J mice)
have a deletion in their Ea gene, resulting in their inability to
produce Ea proteins [5]. As the pairing of both chains is required
for stable cell surface expression, H-2b mice lack I-E expression. It
follows that disruption of either Aa or Ab gene locus does prevent
the cell surface expression of I-A molecules. For the purposes of
understanding MHC-II function in mice, several H-2b strains
completely defective in MHC-II expression have been generated
by targeted disruption of the Ab gene (I-Ab-/-) [1,6], the Aa gene
(I-Aa-/-) [7] and by deletion of both the Aa and Ab locus (I-
Aaxb-/-) [8]. Using one or other of these ko strains, the function of
MHC-II molecules in immune responses has been investigated
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over the past twenty years. Most studies have used I-Ab-/- mice to
examine the role of MHC-II in the response to virus infection,
such as influenza [9–11], LCM [12–14], Theiler [15,16], Vaccinia
[17], and Sendai [18]. I-Aa-/- mice have only been referred to in
two research articles investigating ectromelia (ECT) virus
(orthopoxvirus) [19] and Lassa virus infection [20]. Despite
defective Ab-isotype switching, these studies did not report marked
increases in susceptibility to viral infections. Here we report that
avirulent SFV (aSFV), which only causes asymptomatic infection
in adult wild-type C57BL6/J (B6) mice, caused a very acute and
lethal infection in I-Aa-/- mice. We found this susceptibility to be
unrelated to the lack of functional MHC-II expression, but
associated with increased virus replications in various tissues. Such
increased virus susceptibility appears to be associated with viral
infections in general.
Results and Discussion
The absence of functional MHC-II molecule expression in I-
Aa-/- mice was demonstrated by a lack of cell surface expression of
MHC-II and antibody isotype response to inactivated viruses
(figure 1). Splenocytes from B6 and I-Aa-/- mice were stained for
their cell surface expression of CD19 and I-Ab and analysed by
FACS. Our data show high expression levels of MHC-II molecules
on CD19+ cells from B6 mice compared to that from I-Aa-/- mice
(Figure 1a). In addition, we injected both wild type and I-Aa-/-
mice with gamma-ray inactivated SFV (16106 equivalent pfu/
mouse) intravenously (i.v). Serum samples collected at days 3, 6, 9,
12, 15 and 21 post vaccination were tested for anti-SFV antibody
responses and their isotypes were determined. The data show that
antibody responses in I-Aa-/- mice, in contrast to that of B6 mice,
are restricted to IgM (Figure 1b). Overall, our data confirm the
phenotype of I-Aa-/- mice in terms of inability to antibody isotype
switching and lack of MHC-II expression.
Susceptibility of I-Aa-/- mice to aSFV infections
10-week-old female mice (10 mice/group) were infected i.v with
103 or 107 pfu/mouse of aSFV and survival of animals was
monitored for a period of 21 days. aSFV is known to cause
asymptomatic infection in B6 mice [21], and consistent with this
no mortality was observed (Figure 2a). In contrast, 100% mortality
occurred in I-Aa-/-mice even with the low (103 PFU) infection
dose with a mean time to death of,4 days.
We next investigated the susceptibility of I-Ab-/- mice [6] and
the double knockout I-Aaxb-/- mice [8] to aSFV infection. Again,
10-week-old female mice were infected i.v with aSFV (107 pfu/
mouse) and survival of infected animals was monitored for 21 days.
In contrast to I-Aa-/-mice, no mortality was observed in either I-
Ab-/- or I-Aaxb-/- mice following aSFV infection (Figure 2b). In
general, despite the complete deletion of MHC-II locus in I-
Aaxb-/- mice, infection with aSFV was asymptomatic. Consider-
ing that I-Aaxb-/- mice lack the I-Aa chain, our data suggests that
I-Aa-/- mice susceptibility to aSFV infection is not a consequence
of the lack of MHC-II expression and their associated function. To
Figure 1. Defective MHC-II expression and Ab response in I-Aa-/- mice. A) Cell surface expression of MHC-II on CD19+ cells from B6 and I-Aa-/-
mice. B) B6 and I-Aa-/- mice were immunised with gamma-irradiated SFV and sera analysed for Ab responses and isotype switching.
doi:10.1371/journal.pone.0068458.g001
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eliminate the possibility that I-Aa-/- mice express a Mendelian
dominant inheritance feature conferring susceptibility, we cross-
breed I-Aa-/- and I-Ab-/- mice and infected females of the F1
generation with aSFV (107 pfu/mouse). As expected, F1 mice
behaved like wild-type mice and no mortality was observed as a
result of aSFV infection (Figure 2b).
Susceptibility of I-Aa-/- mice to virus infection is not
determined by cells of haemopoietic origin
To understand the difference between aSFV infection in B6 and
I-Aa-/- mice, we determined virus titres in brain, liver, spleen and
serum at days 1 and 2 post-infection. Mice were infected i.v with
103 pfu of aSFV and virus titres were determined using plaque
assay and expressed as pfu/g of brain, liver and spleen, or pfu/ml
for serum. As shown in figure 3, I-Aa-/- mice show high levels of
viremia, 200 and 400 folds above titres detected in B6 mice at days
1 and 2 post-infection, respectively. This increase in viremia is
associated with high virus load in all tissues tested. Statistical
analysis using unpaired student t test show a significant difference
between B6 and I-Aa-/- mice in virus titres with P,0.05 for all
tested time points for serum, spleen and liver samples as well as
brain samples tested at day 2 post infection.
Considering that MHC-II gene expression is tightly regulated
and mostly restricted to cells of reticulo-endothelial origin such as
thymic epithelium and APCs [1,2] including B cells, we
investigated if somatic or haematopoietic cells are involved in
the susceptibility of I-Aa-/- mice to aSFV infection. Females B6
and I-Aa-/- mice at 6 weeks of age were irradiated with 950 Rad of
gamma-rays using a 137Cs source at CSIRO-Canberra. Irradiated
mice were reconstituted, as previously described, using 56106
bone marrow cells from female donors (either B6 or I-Aa-/-)
instead of foetal liver [22]. Bone marrow chimeras were treated
with antibiotics for 3 weeks post-reconstitution. Successful
establishment of chimeric mice was confirmed by FACS analysis
of cell surface expression of MHC-II on CD19+ cells (data not
shown). 5 weeks post-reconstitution, fully chimeric mice were
injected i.v with 103 pfu/mouse of aSFV and tissue virus titers
tested 1 day post infection using plaque assays. As shown in
figure 4, various tissues from irradiated recipient I-Aa-/- mice show
high virus titres regardless of the genotype of the transferred bone
marrow (whether B6 or I-Aa-/-) following aSFV infection whereas
B6 recipients expressed wt phenotype irrespective of donor bone
marrow origin.
IFN-I response in I-Aa-/- mice
The early mortality following aSFV infection in I-Aa-/- mice
and the increased tissue virus titres led us to investigate the
possibility of a defective IFN-I response in I-Aa-/- mice. Therefore,
sera samples were collected from mice infected with 107 pfu/
mouse aSFV and tested for IFN-a levels. As shown in figure 5A,
higher levels of IFN-I a were detected 24 h post aSFV infection in
serum samples from I-Aa-/- mice compare to B6 mice. Thus the
increased viral susceptibility of I-Aa-/- mice is not due to a
defective IFN-I a response and the heightened IFN-I release in I-
Aa-/- mice is consistent with the heightened viremia in I-Aa-/-
mice.
We next examined the cell surface expression of IFN-I receptors
and found that both wt B6 and I-Aa-/- mice express similar levels
Figure 2. Susceptibility of I-Aa-/- mice to aSFV infection. Mice
were infected i.v with aSFV and animals were monitored for clinical
symptoms and mortality for a period of 21 days (no changes were
observed after day 8). A) Both I-Aa-/- and B6 mice were compared for
their susceptibility to aSFV (103 or 107 pfu/mouse) infection. B) Various
MHC-II knockout mice (I-Aa-/-, I-Ab-/- and I-Aaxb-/-) and F1 of (I-Aa-/- x I-
Ab-/-) were compared for their susceptibility to aSFV (107 pfu/mouse)
infection.
doi:10.1371/journal.pone.0068458.g002
Figure 3. Tissue virus titres. B6 (open symbols) and I-Aa-/- (solid
symbols) mice were infected with aSFV (103 pfu/mouse). Tissues were
harvested at days 1 and 2 post infection and virus titres were estimated
using plaque assay.
doi:10.1371/journal.pone.0068458.g003
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(Figure 5B). We have previously reported a phenomenon of IFN-I
mediated partial lymphocyte activation during acute viral infection
and have illustrated the essential role of IFN-I receptors in this
phenomenon [23]. To address the functionality of IFN-I receptors
in I-Aa-/- mice, we treated splenocytes from B6, I-Aa-/-, and IFN-
IR-/- mice with 1000 U/ml of recombinant IFN-I (r-IFN-b).
Following incubation in vitro for 12 h. Cell surface expression of
CD69 and CD25 was evaluated using FACS. As shown in
figure 5C, splenocytes from both B6 and I-Aa-/-, in contrast to
IFN-IR-/-, mice show increased expression levels of CD69 and
CD25 on B220+ cells following treatment with rIFN-b. This
illustrates the fact that I-Aa-/- mice have functional IFN-I
receptors. Importantly, IFN-I mediated anti-viral immunity
involves various signalling pathways and mice defective in STAT1,
for example, have been shown to be susceptible to viral infections
[24]. Unlike previously published work regarding STAT1-/- mice,
cells of I-Aa-/- mice are responsive to IFN-I treatment as evident
by the induction of CD69 expression (figure 5B). Overall, our data
show that the increased susceptibility of I-Aa-/-mice to aSFV
infection is neither associated with a lack of IFN-I secretion nor a
defective IFN-I receptor function. To further study this phenom-
enon of increased viral susceptibility, we investigated the possibility
of enhanced viral replication per se using in vitro cultures of
macrophages, splenocytes and fibroblasts.
High level of viral replication in vitro
B6 wt and I-Aa-/- mice were injected i.p with thioglycollate
(1 ml/mouse) and three days later, peritoneal macrophages and
splenocytes collected. 16106 nucleated cells were infected with
aSFV at a MOI of 0.5 pfu/cell. Virus replication in tissue cultures
was estimated 24 and 48 hours later by plaque assay. As shown in
figure 6A, significantly higher SFV replication was found in
splenocyte and macrophage cultures derived from I-Aa-/- mice
than that from B6 mice. Residual virus titres of,26105 after 24 h,
and ,1.56104 after 48 h were obtained following in vitro
incubation of virus in the absence of cells. These control virus
titres were comparable to that obtained from infected splenocyte
and macrophage cultures of B6 mice, which confirms that little to
no virus replication occurs in vitro in such cells of wt mice. This
contrasts with high virus titres (100–200 folds higher) detected in I-
Aa-/- splenocyte and macrophage cultures. To test whether in
vitro cultures of I-Aa-/- macrophages can also support the
replication of other alphaviruses, we evaluated virus replication
of Ross River Virus, Sindbis and Bebaru at 24 and 48 h post-
infection. As shown in figure 6B, macrophages from I-Aa-/- mice,
but not from B6 mice, supported significant replication of all the
alphaviruses tested at 48 h post infection. These data indicate that
macrophages from I-Aa-/- mice, but not B6 mice, support
replication of aSFV as well as other alphaviruses. It has been
reported previously that in vitro aSFV infection of spleenic
macrophages is associated with viral antigen presentation without
release of infectious virus particles [25]. This block of viral
replication/release is absent in macrophages of I-Aa-/- mice.
In addition to virus replication experiments using ex-vivo cells,
we generated tumor cell lines from I-Aa-/-and B6 mice that are
not constitutively expressing MHC-II, for in vitro virus growth
studies. We generated stable methyl colantherine induced I-Aa-/-
and B6 fibroblast cell lines using a similar protocol to that used
previously for the generation of MC57 cell line from the wild type
B10 mice [26]. Triplicate flasks from I-Aa-/- and B6 cell lines were
infected with aSFV using a MOI of 10 or 0.1 pfu/cell. Culture
supernatants were harvested 24 h later and virus titres estimated
using plaque assays. As shown in figure 7, significantly higher virus
titres were obtained from the I-Aa-/- cell line compared to that of
the B6 cell line with P values of 0.018 and 0.0018 for both 10 and
0.1 pfu, respectively, using unpaired student t test. This data
confirms that the susceptibility of I-Aa-/- mice to virus infection is
caused by an enhanced viral replication per se. These cell lines will
be a vital tool to investigate the molecular and genetic basis of the
mechanisms responsible for this unusual phenomenon.
Figure 4. Somatic cells of I-Aa-/- mice support high levels of virus replication. Females B6 and I-Aa-/- mice were lethally irradiated and
reconstituted with bone marrow cells from female donors of either B6 or I-Aa-/- mice. Bone marrow chimeras were infected i.v with aSFV (103 pfu/
mouse) and tissue virus titers were estimated at day 1 post-infection using plaque assay.
doi:10.1371/journal.pone.0068458.g004
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Susceptibility of I-Aa-/- mice to other virus infections
To test if this increased susceptibility of I-Aa-/- mice to
alphavirus infections also applied to other virus infections, we
tested viral replication of ectromelia (ECT) virus (poxviridae: DNA
genome) and West Nile Virus (WNV) (Flaviviridae: RNA genome).
I-Aa-/- and wild-type mice were infected i.v with 103 pfu/mouse
of ECT-Moscow strain and spleens were harvested at day 3 p.i and
virus titres estimated using plaque assays. The data clearly show
significant enhancement of ECT replication in spleens of I-Aa-/-
mice compared to wild-type controls with P value of 0.001 using
unpaired student t test (Figure 8A). In addition, all I-Aa-/- mice
designated to be sampled at day 6 post-infection had died prior to
sampling. No-mortality occurred, as expected, in the wild-type
control group. I-Aa-/- mice have been used previously to
investigate the role of Ab responses in the recovery from virulent
ECT infection [19]. While virus replication in I-Aa-/- mice was
not evaluated. The researchers used s.c infection and reported that
ECT-Moscow infection cause lethality (at days 12–25 post-
infection) in primed and un-primed I-Aa-/- mice. We suspect that
the route of administration may have influenced the early
mortality detected in our model (day 6 post-infection using i.v).
Importantly, our data clearly illustrates the significant increase in
ECT replication in I-Aa-/- mice (2 log difference) compare to that
of B6 mice. We also used the flavivirus WNV as an additional virus
model and infected both I-Aa-/- and B6 mice i.v with 103 pfu/
mouse and estimated brain virus titres at day 8 p.i. Our data show
a significant increase in the mean virus titres (4 log difference) in
brain tissues from I-Aa-/- mice compared to B6 wild-type controls
with P value of 0.023 using unpaired student t test (Figure 8B).
These data indicate that I-Aa-/- mice support high levels of virus
replication of a variety of virus types compared to that of wt B6
mice and this is observed with viruses that employ vastly different
replication strategies.
In conclusion, we have uncovered a very unusual phenomenon
in I-Aa-/- mice namely a vastly increased susceptibility to aSFV
and other virus infections. This susceptibility is associated with
enhanced virus replication (alphaviruses, flaviviruses, and ortho-
poxviruses) in a variety of tissues in vitro and in vivo. This
increased viral susceptibility is unrelated to the MHC-II negative
phenotype and appears not to involve a defect in the IFN-I
mediated anti-viral response. Thus, our data indicate that I-Aa-/-
mice may carry two distinctive and unrelated phenotypes: a
defective MHC-II expression and an enhanced virus replication
not related to defective antigen presentation.
Figure 5. IFN-I responses in I-Aa-/-mice. A) I-Aa-/-and B6 mice were infected with aSFV and serum samples were collected 24 h post infection and
tested for IFN-Ia levels. B) Splenocytes from naı¨ve I-Aa-/- and B6 mice were tested for cell surface expression of IFN-I receptor. C) Splenocytes from B6,
I-Aa-/- and IFN-aR1 -/- mice were incubated in vitro with 1000 U/ml of r-IFN-b (black line) or medium alone (filled grey) for 12 hours and tested for cell
surface expression of CD69 and CD25. The expression profile of B220+ cells is shown.
doi:10.1371/journal.pone.0068458.g005
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Materials and Methods
Ethics statement
This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the Australian National University.
Experimental protocol was approved by the Animal Ethics
Committee of the Australian National University, ACT, Australia
(Permit Number: JIG47.06).
Animals
wild type C57BL/6J (B6) mice and syngeneic mice deficient in
MHC-II molecules as a result of a defective Ab gene (I-Ab-/-) [6],
a disrupted Aa gene (I-Aa-/-) [7], a complete deletion of Aa and
Ab locus (I-Aa/b-/-) [8], and IFN-a receptor knockout (IFN-IR-/-)
[27] were used in this study. Throughout this study, 10-week-old
female mice were used. Mice were bred under specific pathogen-
free conditions and supplied by the Animal Breeding Facilities at
the John Curtin School of Medical Research, Australian National
University.
Cells and viruses
Vero (African green monkey kidney) and BHK (baby hamster
kidney) were originally obtained from the American Type Culture
Collection (ATCC). In addition, de novo methylcolantherine
induced I-Aa-/- and B6 fibroblast cell lines were prepared as has
Figure 6. Viral replication in vitro. Splenocytes and peritoneal macrophages obtained from B6 (open symbols) and I-Aa-/- (solid symbols) mice
support high levels of alphaviruses replication in vitro. A) Splenocytes and macrophages were infected in vitro with aSFV using MOI of 0.5 pfu/cells. B)
Macrophages were infected with RRV, Sindbis, and Bebaru using MOI of 0.5 pfu/cells. Culture supernatants were sampled 24 and 48 h post infection
and virus titres were estimated using plaque assay.
doi:10.1371/journal.pone.0068458.g006
Figure 7. I-Aa-/- cell line supports increased viral replication
compared to the B6 cell line generated in parallel. 106 cells from
B6 (open symbols) and I-Aa-/- (solid symbols) fibroblast lines were
infected with aSFV (MOI of 10 or 0.1 pfu/cell) and culture supernatants
were assayed 24 h later for virus titres by plaque assay.
doi:10.1371/journal.pone.0068458.g007
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been described [26]. All cells were maintained in Eagle’s minimal
essential medium (EMEM) plus 5% foetal calf serum (FCS) and
grown at 37uC in a humidified conditions with 5% CO2.
Working stocks of avirulent SFV (strain A7) were prepared by
infecting semi-confluent BHK cell monolayers at a multiplicity of
0.5 pfu per cell. Infected cells were incubated for 24 h and culture
supernatants harvested, centrifuged at 1200 g for 4 min to remove
cell debris and stored in single-use aliquots at 280uC. Virus titre
determined by plaque assay on Vero cells and the titer of the
working stocks of aSFV was 16108 pfu/mL. Other alphaviruses
(Ross River virus, Sindbis virus, and Bebaru), ectromelia virus
(orthopoxvirus) and West Nile Virus (Flavivirus), from previously
published work [28–30], have also been used in few experiments.
For inactivated SFV, virus stocks were subject to 1.36106 Rad of
gamma-irradiation (137Cs source at CSIRO-Canberra) and virus
sterility was confirmed by lack of plaque formation on vero cells.
Plaque assay
Virus titres were estimated by plaque formation on semi-
confluent monolayers of Vero cells as previously described [31].
Briefly, samples were serially diluted on ice in HBSS, pH 7.6,
containing 0.2% BSA, and cells inoculated in duplicate with
0.1 ml aliquots of the diluted samples. Adsorption was for 1 h at
37uC followed by the addition of an agar overlay medium. After
48 h incubation at 37uC, cells were fixed with 5% paraformalde-
hyde (BDH chemicals, Aust.) for 1 h. Over-layers were removed,
and fixed cells were stained with 0.2% crystal violet in ddH2O.
The stain was aspirated and plaques counted.
For virus determination in infected mouse tissues, animals were
sacrificed at a given time post-infection, tissues were aseptically
removed, snap-frozen in liquid nitrogen or dry ice, and stored at
270uC. 10% (weight/volume) tissue suspensions in ice-cold HBSS
(pH 7.6) containing 0.2% BSA were homogenized, clarified by
centrifugation (18,0006g for 5 min at 4uC), and supernatants were
stored in aliquots at 280uC. The limit of virus detection by plaque
assay in tissues and serum samples of infected mice was 102 pfu/g
or ml, respectively. In addition, brain, spleen, and muscle tissues
from uninfected animals were homogenised in the presence of a
known amount of virus and used as controls. Plaque titration
indicated no loss of virus titers due to tissue components released
during homogenisation. Virus determination for ECTV and WNV
was carried out as previously described [29,30].
IFN-a levels in sera
Sera from SFV-infected B6 and I-Aa-/- mice were collected at
day 1 p.i. (3 mice/strain) and tested for IFN-a levels using a
sandwich ELISA kit according to the manufacturer’s instructions
(US Biological). For each experiment, a standard curve in the
range of 0 2500 pg/ml IFN-a was generated and used to estimate
the concentration of serum IFN-a of tested samples. Detection
limit for IFN-a was 12.5 pg/ml.
Flow cytometric analysis
Spleens from infected and control mice were harvested and red
cell-depleted single cell suspensions prepared. Lymphocytes
(16106) were stained using fluorescent-conjugated anti-CD3, -
CD4, -CD8, -CD19, -B220, -CD69, and -CD86 specific Abs (BD
Pharmingen) and cell surface expression of these markers was
assessed by flow cytometry using BD LSR II (BD Biosciences,
Australia). In addition, cell surface expression levels of IFN-I
receptor on splenocytes from B6 and I-Aa-/- mice were assessed by
flow cytometry using BD LSR II (BD Biosciences, Australia) using
I-Ab specific Abs (BD Pharmingen). Dead cells were labeled with
7-aminoactinomycin D (Sigma-Aldrich) and Fc receptors were
blocked by the addition of anti-mouse CD16/CD32 (Fc III/II
receptor) Ab (BD Pharmingen). Fc receptor Ab and 7-aminoacti-
nomycin D were added before the addition of cell subpopulation-
and activation marker-reactive Abs.
Bone Marrow Chimeras
Females B6 and I-Aa-/- mice were lethally irradiated with 950
Rad from a 137Cs source (CSIRO-Canberra) at 6 weeks of age,
and reconstituted, as previously described [32], with 56106 bone
marrow cells. Bone marrow chimeras were treated with antibiotics
(Neomycin and Polymyxin B sulfate) for 3 weeks post-reconstitu-
tion. 2 weeks later (5 weeks post-reconstitution), 2 mice from each
group were sacrificed and splenocytes were stained using
fluorescent-conjugated anti-CD19 and I-Ab specific Abs (BD
Figure 8. Enhanced virus replication in tissues of I-Aa-/- mice. Knockout and wild-type mice were infected i.v with 103 pfu/mouse of ECT-
Moscow (A) or WNV (Sarafend) (B) and animals were monitored for clinical symptoms. Tissues were harvested at day 3 post infection for ECT-Moscow
infected animals and day 8 post infection for WNV infected animals and virus titres were estimated using plaque assays.
doi:10.1371/journal.pone.0068458.g008
Enhanced Virus Replication in MHC-II Knockout Mice
PLOS ONE | www.plosone.org 7 June 2013 | Volume 8 | Issue 6 | e68458
Pharmingen) and cell surface expression of MHC-II on CD19+
cells was assessed using flow cytometry using BD LSR II (BD
Biosciences, Australia). The remaining mice were injected i.v with
103 pfu/mouse of aSFV and various tissues were harvested at
predetermined time points to test for virus titers using plaque
assay.
Statistical analysis
Data were expressed as mean 6 standard error of means (SEM)
and analysed using a two-tailed student t test. A p-value of,0.05
was deemed significant.
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